Id1 enhances human ovarian cancer endothelial progenitor cell angiogenesis via PI3K/Akt and NF-κB/MMP-2 signaling pathways

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Su, Yajuan ^a   Gao, Lingjuan ^b   Teng, Lichen ^a   Wang, Ying ^a   Cui, Jialin ^a   Peng, Shiyun ^a   Fu, Songbin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Endothelial progenitor cells; Id1; NF B MMP 2; PI3K Akt

Indexed keywords

DOUBLE STRANDED DNA; GELATINASE A; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 1; LENTIVIRUS VECTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; ENDOTHELIAL CELLS; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GREEN FLUORESCENT PROTEINS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; OVARIAN NEOPLASMS; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84878249534     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-132     Document Type: Article

References (23)

1. Kopp HG, Ramos CA, Rafii S. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol 2006, 13:175-181. 10.1097/01.moh.0000219664.26528.da, 2945883, 16567962.
2. Asahara T, Takahashi T, Masuda H. VEGF contributes to postnatal neovascularization by mobilizing bone marrow derived endothelial progenitor cells. Embo J 1999, 18:3964-3972. 10.1093/emboj/18.14.3964, 1171472, 10406801.
3. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353. 10.1161/01.RES.0000137877.89448.78, 15321944.
4. Gao D, Nolan DJ, Mellick AS. EPCs control the angiogenic switch in mouse lung metastasis. Science 2008, 319:195-198. 10.1126/science.1150224, 18187653.
5. Maw MK, Fujimoto J, Tamaya T. Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer 2009, 9:430. 10.1186/1471-2407-9-430, 2796680, 20003244.
6. Lyden D, Young AZ, Zagzag D. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 2007, 104:1260-1265.
7. Jankovic V, Ciarrocchi A, Boccuni P. Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells. Proc Natl Acad Sci U S A 2007, 104:1260-1265. 10.1073/pnas.0607894104, 1783103, 17227850.
8. Shaked Y, Ciarrocchi A, Franco M, Lee CR, Man S, Cheung AM, Hicklin DJ, Chaplin D, Foster FS, Benezra R, Kerbel RS. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006, 313(5794):1785-1787. 10.1126/science.1127592, 16990548.
9. Su YJ, Zheng L, Wang Q, Bao J, Zh C, Ailan L. The PI3K/ Akt pathway upregulates Id1 and integrin α4 to enhance recruitment of human ovarian cancer endothelial progenitor cells. BMC Cancer 2010, 10:459. 10.1186/1471-2407-10-459, 2940800, 20796276.
10. Su Y, Zheng L, Wang Q, Li W, Cai Z, Xiong S, Bao J. Quantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancer. J Exp Clin Cancer Res 2010, 29(1):27. 10.1186/1756-9966-29-27, 2857826, 20334653.
11. Tsuchiya K, Kim Y, Ondrey FG, Lin J. Characterization of a temper-ature-sensitive mouse middle ear epithelial cell line. Acta Otolaryngol 2005, 125:823-829. 10.1080/00016480510031533, 16158528.
12. Gao DC, Nolan D, McDonnell K, Vahdat L, Benezra R. Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta 2009, 1796:33-40. 3649840, 19460418.
13. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 2007, 21:1546-1558. 10.1101/gad.436307, 1891431, 17575055.
14. Peters BA, Diaz LA, Polyak K. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005, 11:261-262. 10.1038/nm1200, 15723071.
15. Duda DG, Cohen KS, Kozin SV. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood 2006, 107:2774-2776. 10.1182/blood-2005-08-3210, 1895376, 16339405.
16. Mieno S, Boodhwani M, Robich MP, Clements RT, Sodha NR, Sellke FW. Effects of diabetes mellitus on VEGF-induced proliferation response in bone marrow derived endothelial progenitor cells. J Card Surg 2010, 25(5):618-625. 10.1111/j.1540-8191.2010.01086.x, 2958227, 20626511.
17. Spring H, Schuler T, Arnold B, Hammerling GJ, Ganss R. Chemo-kines direct endothelia l progenitors int o tumor neovessels. Proc Natl Acad Sci USA 2005, 102:18111-18116. 10.1073/pnas.0507158102, 1312396, 16326806.
18. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegue E, Song H, Vandenberg S, Johnson RS, Werb Z. HIF1 α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008, 13:206-220. 10.1016/j.ccr.2008.01.034, 2643426, 18328425.
19. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP. VEGF and PlGF promote adult vasculogenesis by enhancing EPC re-cruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006, 20:1495-1497. 10.1096/fj.05-5137fje, 16754748.
20. Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC. Abrogation of TGFβ signal-ing in mammary carcinomas recruits Gr-1+CD11b+myeloid cells that promote metastasis. Cancer Cell 2008, 3:23-35.
21. Dutta S, Wang FQ, Wu HS, Mukherjee TJ, Fishman DA. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC). Gynecol Oncol 2011, 23(1):129-137.
22. Lin J, Guan Z, Wang C, Feng L, Zheng Y, Caicedo E, Bearth E, Peng JR, Gaffney P, Ondrey FG. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin Cancer Res 2010, 1;16(1):77-87.
23. Mern DS, Hoppe-Seyler K, Hoppe-Seyler F, Hasskarl J, Burwinkel B. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells. Breast Cancer Res Treat 2010, 124(3):623-633. 10.1007/s10549-010-0810-6, 20191379.